Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10967201 | Vaccine | 2013 | 12 Pages |
Abstract
⺠We modeled deaths averted in persons vaccinated in 73 GAVI-eligible countries. ⺠Projected use of nine antigens during 2011-2020 is expected to avert 10 million deaths. ⺠Routine and supplemental measles vaccination is expected to avert an additional 13 million deaths. ⺠Most deaths averted will be in Africa and Southeast Asia, regions with high mortality.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Lisa A. Lee, Lauren Franzel, Jessica Atwell, S. Deblina Datta, Ingrid K. Friberg, Sue J. Goldie, Susan E. Reef, Nina Schwalbe, Emily Simons, Peter M. Strebel, Steven Sweet, Chutima Suraratdecha, Yvonne Tam, Emilia Vynnycky, Neff Walker, Damian G. Walker,